NCT04342728View on ClinicalTrials.gov

Coronavirus 2019 (COVID-19)- Using Ascorbic Acid and Zinc Supplementation

NACompletedINTERVENTIONAL
Enrollment

214

Participants

Timeline

Start Date

April 8, 2020

Primary Completion Date

December 30, 2020

Study Completion Date

February 11, 2021

Conditions
COVIDCorona Virus Infection
Interventions
DIETARY_SUPPLEMENT

Ascorbic Acid

Readily available marketed open label ascorbic acid

DIETARY_SUPPLEMENT

Zinc Gluconate

Readily available marketed open label zinc gluconate

DIETARY_SUPPLEMENT

Ascorbic Acid and Zinc Gluconate

Readily available marketed open label ascorbic acid and zinc gluconate

OTHER

Standard of Care

Readily available prescribed medications/ supplements- None study supplements

Trial Locations (2)

33331

Cleveland Clinic, Weston

44195

Cleveland Clinic, Cleveland

All Listed Sponsors
lead

The Cleveland Clinic

OTHER

NCT04342728 - Coronavirus 2019 (COVID-19)- Using Ascorbic Acid and Zinc Supplementation | Biotech Hunter | Biotech Hunter